Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ali Falahati
Observed names:
A Falahati,
A. Falahati
Institution:
Kashan University of Medical Sciences
Observed institutions:
Novo Nordisk (Denmark),
Kashan University of Medical Sciences,
Ferring Pharmaceuticals (Denmark),
University of Otago
ORCID:
0009-0001-5836-5593
Observed ORCID:
0009-0001-5836-5593
OpenAlex ID:
A5109094661
Mild Renal Impairment and the Efficacy and Safety of Liraglutide
2010
·
Jaime A. Davidson
, Jason Brett
, et al.
·
Endocrine Practice
·
88
Comparison of the Efficacy and Tolerability Profile of Liraglutide, a Once-Daily Human GLP-1 Analog, in Patients With Type 2 Diabetes ≥65 and <65 Years of Age: A Pooled Analysis from Phase III Studies
2011
·
Bruce W. Bode
, Jason Brett
, et al.
·
The American Journal of Geriatric Pharmacotherapy
·
71
Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time
2009
·
B. Gallwitz
, A. Vaag
, et al.
·
International Journal of Clinical Practice
·
60
PDF
Source and kinetics of interleukin-6 in humans during exercise demonstrated by a minimally invasive model
2010
·
Anders Dyhr Toft
, Ali Falahati
, et al.
·
European Journal of Applied Physiology
·
49
Efficacy and safety of controlled‐release dinoprostone vaginal delivery system ( PROPESS ) in Japanese pregnant women requiring cervical ripening: Results from a multicenter, randomized, double‐blind, placebo‐controlled phase III study
2020
·
Hiroaki Itoh
, Keisuke Ishii
, et al.
·
Journal of obstetrics and gynaecology research
·
38
PDF
Reductions in lipids and CV risk markers in patients with type 2 diabetes treated with liraglutide: a meta-analysis
2009
·
J. Plutzky
, A. Garber
, et al.
·
Canadian Journal of Diabetes
·
36
Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double‐blind placebo‐controlled parallel‐group development program
2019
·
Osamu Yamaguchi
, Kristian V. Juul
, et al.
·
LUTS Lower Urinary Tract Symptoms
·
32
PDF
Anticonvulsant activities of Sambucus nigra.
2016
·
R Ataee
, A Falahati
, et al.
·
PubMed
·
29
Safety, tolerability, and pharmacokinetics of single‐ and multiple‐ascending doses of olamkicept: Results from randomized, placebo‐controlled, first‐in‐human phase I trials
2024
·
Frank‐Dietrich Wagner
, Stefan Schreiber
, et al.
·
Clinical and Translational Science
·
15
One-year cumulative live birth rate associated with the number of oocytes in ovarian stimulation with follitropin delta: a pooled analysis of four randomized controlled trials
2025
·
Rita Lobo
, Samuel Santos-Ribeiro
, et al.
·
Human Reproduction
·
11
PDF
Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies
2009
·
Bernard Zinman
, John B. Buse
, et al.
·
Diabetes
·
10
Oocyte yield and live birth rate after follitropin delta dosing and fresh embryo transfer: an individual patient data meta-analysis
2024
·
Rita Lobo
, Ali Falahati
, et al.
·
Reproductive BioMedicine Online
·
9
PDF
Spatiotemporal expression of activin receptor-like kinase-5 and bone morphogenetic protein receptor type II in the ovary of shortfinned eel, Anguilla australis
2020
·
Ali Falahati
, Yuichi Ozaki
, et al.
·
Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
·
9
Liraglutide, a once-daily human GLP-1 analogue, reduces systolic blood pressure within 2 weeks in patients with type 2 diabetes
2009
·
V. Fonseca
, A. Falahati
, et al.
·
Canadian Journal of Diabetes
·
7
Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
2009
·
Wolfgang E. Schmidt
, Stephen Gough
, et al.
·
Diabetologia
·
7
adding liraglutide to existing therapy improves glycaemic control: evidence from a meta-analysis of six large randomised clinical trials
2009
·
R. Pratley
, M. Nauck
, et al.
·
Canadian Journal of Diabetes
·
6
High Prevalence of Advanced NAFLD in Type 2 Diabetic Patients with Normal Liver Enzymes and Effect of Liraglutide on NAFLD: Meta-Analysis of the LEAD Program
2010
·
Matthew J. Armstrong
, A Falahati
, et al.
·
Diabetes
·
4
OP03 Effects of two years of liraglutide treatment on fatty liver disease in patients with type 2 diabetes: analysis of the Liraglutide Effect and Action in Diabetes-2 extension trial
2010
·
M Armstrong
, A Falahati
, et al.
·
Gut
·
2
[Liraglutide and glimepiride on glycaemic control in type 2 diabetes in the Mexican cohort (LEAD 3)].
2010
·
Pedro García-Hernández
, María del Rosario Arechavaleta-Granell
, et al.
·
PubMed
·
2
P-458 Association between endometrial thickness and live birth in fresh embryo transfer cycles: An individual patient data meta-analysis based on randomised controlled trials with follitropin delta
2025
·
R Lobo
, A Falahati
, et al.
·
Human Reproduction
·
1
PDF
High prevalence of advanced NAFLD in type 2 diabetic patients with unremarkable liver enzymes and effect of liraglutide on NAFLD: meta-analysis of the LEAD Program
2010
·
Matthew J. Armstrong
, A Falahati
, et al.
·
Diabetologia
·
1
Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c)
2010
·
Stephen Gough
, Sten Madsbad
, et al.
·
Diabetes
·
1
Impact of liraglutide on reaching target HbA1c without weight gain or hypoglycaemia, versus other T2D therapies
2009
·
B. Zinman
, J. Buse
, et al.
·
Canadian Journal of Diabetes
·
1
Efficacy of follitropin delta in potential low responders: a pooled analysis of individual patient data from five randomized controlled trials
2026
·
Rita Lobo
, Ali Falahati
, et al.
·
Frontiers in Endocrinology
PDF
Common Misconceptions Regarding Diabetes Mellitus among Clients Attending Comprehensive Health Service Centers: A Qualitative Study
2026
·
Ali Fakhri
, Ali Falahati
·
Iranian Journal of Diabetes and Metabolism
Show more works
View as search
Works count:
33
Citation count:
489
H-index:
10
I10-index:
11
Year
Topic
Type